⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Fluticasone/salmeterol
فلوتیکازون-سالمترول (سرتاید)
🌬️ Respiratory & coughInhaled ICS + LABA
Market / country: 🇺🇸 USA
Advair Diskus (US) · Seretide (GB)
🧮 Dose calculator
Asthma and chronic lung disease (reversible airflow obstruction) · Regimen source: FDA Advair Diskus · 2.1
- • Strength 100/50, 250/50 or 500/50 by severity and prior ICS dose. More than 1 inhalation twice daily not recommended. Not for acute attacks. FDA Advair Diskus · 2.1FDA Advair Diskus · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Primary treatment of status asthmaticus or acute COPD episodes; severe milk-protein or component hypersensitivity. FDA Advair Diskus · 4
- ⛔ Not established under 4 years. FDA Advair Diskus · 8.4
Formulations
- 100/50 mcg per inhalation (fluticasone/salmeterol) — inhaler 🇺🇸 USA FDA Advair Diskus · 3
- 250/50 mcg per inhalation (fluticasone/salmeterol) — inhaler 🇺🇸 USA FDA Advair Diskus · 3
- 500/50 mcg per inhalation (fluticasone/salmeterol) — inhaler 🇺🇸 USA FDA Advair Diskus · 3
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Advair Diskus · 3FDA Advair Diskus · 2.1FDA Advair Diskus · 2FDA Advair Diskus · 2.2FDA Advair Diskus · 4FDA Advair Diskus · 8.4
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Clinical review⚠ Unverified